Trial · NCT01665053
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants With Target Lesion Failure (TLF) at 12 Months | 12 months | TLF is defined as any ischemia-driven revascularization of the target lesion, myocardial infarction (Q-wave and non-Q-wave) related to the target vessel, or cardiac death. |
| Secondary | Percentage of Participants With Target Lesion Revascularization (TLR) at 12 Months. | 12 months | The TLR overall rate includes: TLR Percutaneous Coronary Intervention (PCI) \& TLR Coronary Artery Bypass Graft (CABG). |
| Secondary | Percentage of Participants With Target Vessel Revascularization (TVR) at 12 Months. | 12 months | TVR overall includes: TVR PCI \& TVR CABG. |
| Secondary | Percentage of Participants With Target Vessel Failure (TVF) at 12 Month. | 12 months | Target Vessel Failure is defined as any ischemic-driven revascularization of the target vessel, MI related to the target vessel, or any cardiac death. |
| Secondary | Percentage of Participants With Myocardial Infarction at 12 Month. | 12 months | The MI rate includes: MI's related to the Target Vessel, MI's with unknown relationship to the Target Vessel and MI's not related to the Target Vessel. |
| Secondary | Percentage of Participants With Cardiac Death at 12 Month. | 12 months | |
| Secondary | Percentage of Participants With Non-Cardiac Death at 12 Month. | 12 months | |
| Secondary | Percentage of Patients That Died at 12 Months. | 12 months | The Death rate includes Cardiac- \& Non-Cardiac Death. |
| Secondary | Percentage of Patients With Cardiac Death or Myocardial Infarction (MI) at 12 Month. | 12 months | |
| Secondary | Percentage of Participants Who Died or Had an Myocardial Infarction (MI) at 12 Month. | 12 months | |
| Secondary | Percentage of Participants Who Died, Had an Myocardial Infarction (MI) or a Target Vessel Revascularization (TVR) at12 Month. | 12 months | |
| Secondary | Percentage of Participants With a ARC (Academic Research Consortium) Stent Thrombosis Rate at 12 Month. | 12 months | |
| Secondary | Percentage of Patients With a Stroke at 12 Month. | 12 months | The stroke rate includes: Ischemic- , Hemorraghic- \& Undetermined Stroke. |
| Secondary | Periprocedural Technical Success Rate. | Day 1 (periprocedure) | Technical Success Rate is defined as successful delivery and deployment of the study stent to the target vessel, without balloon rupture or stent embolization, and post-procedure diameter stenosis less then 30% in 2 near-orthogonal projections with TIMI 3 flow in the target lesion. Technical success is lesion based. |
| Secondary | Periprocedural Clinical Procedural Success Rate | Day 1 (periprocedure) | Procedural Success Rate is defined as post-procedure diameter less then 30% in 2 near-orthogonal projections with TIMI 3 flow in all target lesions without occurrence of in-hospital cardiac death, MI, TVR. Procedural success rate is subject based. |
| Secondary | Percentage of Participants With a Target Lesion Failure (TLF) at 12 Month. | 12 month | |
| Secondary | Percentage of Patients With Revascularization (=All Revascularizations) at 12 Month. | 12 Month | All CEC adjudicated revascularization at 12 month (Intent to treat population). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01665053/registered